Chemo-Gut Probiotic Study
The Chemo-Gut Probiotic Trial uses a double-blinded placebo-controlled design, in which cancer survivors who have undergone chemotherapy will be randomly assigned to take either a novel oral probiotic treatment or a placebo pill, once daily, for 12 weeks.
The purpose of this study is to determine whether the probiotic treatment impacts gastrointestinal symptoms, mental health, and the gut microbiome.
Want to learn more about Chemo-Gut?
-
Be experiencing GI issues
-
Have been diagnosed with hematological cancers (leukemia, Hodgkin’s, and non-Hodgkin lymphoma), breast, osteosarcoma, Ewing’s sarcoma, thyroid, head and neck (e.g. laryngeal, esophageal), stomach, gynecological (cervical, endometrial), prostate, or testicular cancer.
-
Have received chemotherapy.
-
Be within 5 years from your final cancer treatments.
-
Be 18 years or older
-
Be willing to provide stool samples.
-
Be able to speak, read, and write English sufficiently to participate in all activities.